<DOC>
	<DOC>NCT03023774</DOC>
	<brief_summary>Evaluate the effectiveness of granulocyte colony-stimulating factor (GCSF) in the treatment of thin endometrium or in women with recurrent implantation failure in ICSI cycles</brief_summary>
	<brief_title>Use of Gcsf in Patients With Recurrent Ivf/Icsi Failure</brief_title>
	<detailed_description>Prospective analytical study which will be conducted at a private IVF center starting from june 2016. the study will be recruited from both the fertility clinics and centers by fulfilling inclusion and exclusion criteria , all patient will be subjected to complete history taking medical and fertility history including previous induction or implantation failure. patients will be randomized into two groups, group A will be treated with neupogen 30 international unit (IU) and group B will be treated with clexane 40mg and estrogen. study procedure: ovaries were stimulated with standard protocol (long GnRH Agonist) or gonadotrophic releasing hormone (GnRH Antagonist, when at least 3 follicles achieved 18 mm diameter, Human chorionic gonadotrophic (hCG) (10000 IU) was administered for ovulation triggering, transvaginal oocyte retrieval was performed at 36-38 hours after injection of hCG . the oocytes were fertilized by intracytoplasmic sperm injection (ICSI) method. the thickness of endometrium was evaluated on the day of oocyte retrieval and syringe which containing (300 mcg/1 ml) GCSF (neupogen) was infused slowly in the uterine cavity and after 5 days (before embryo transfer) endometrial thickness was evaluated again. all patients received oral and parenteral progesterone for luteal phase support.</detailed_description>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>male partner with normal semen analysis according to world health organization (WHO) 2010. female partner under the age of 36 presented with: athin endometrium (less 7 mm on transvaginal ultrasound) or b previous history multiple unexplained female with no history of Asherman's syndrome , fibroids, and polyps in diagnostic hysteroscopy women with sickle cell disease, renal insufficiency, upper respiratory infection or pneumonia, chronic neutropenia, known past or present malignancy</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>36 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>